公式動画ピックアップ

AAPL   ADBE   ADSK   AIG   AMGN   AMZN   BABA   BAC   BL   BOX   C   CHGG   CLDR   COKE   COUP   CRM   CROX   DDOG   DELL   DIS   DOCU   DOMO   ESTC   F   FIVN   GILD   GRUB   GS   GSK   H   HD   HON   HPE   HSBC   IBM   INST   INTC   INTU   IRBT   JCOM   JNJ   JPM   LLY   LMT   M   MA   MCD   MDB   MGM   MMM   MSFT   MSI   NCR   NEM   NEWR   NFLX   NKE   NOW   NTNX   NVDA   NYT   OKTA   ORCL   PD   PG   PLAN   PS   RHT   RNG   SAP   SBUX   SHOP   SMAR   SPLK   SQ   TDOC   TEAM   TSLA   TWOU   TWTR   TXN   UA   UAL   UL   UTX   V   VEEV   VZ   WDAY   WFC   WK   WMT   WORK   YELP   ZEN   ZM   ZS   ZUO  

  公式動画&関連する動画 [Ep 90 | Can AI Make Sense of Pharma’s Messiest Data?]

Human biology is extraordinarily complex, and researchers often have only fragments of information to work with. Brian Martin compares it to looking at a skyscraper through a keyhole: you can see something clearly, but only a tiny piece of the whole. Recorded at EVOLVE26 Singapore, this episode of The AI Forecast brings Paul Muller together with Brian Martin, CTO of Applied AI at Cloudera and co-founder of Rare Hopes NFP, to explore what one of the world’s most data-intensive industries can teach us about AI and decision-making. Brian explains how pharmaceutical R&D turns sparse, fragmented data into insights that support drug discovery. With a new drug potentially requiring years of development and billions of dollars in investment, better predictions can have an enormous impact on how quickly promising treatments reach patients. Paul and Brian explore: - How knowledge graphs can reveal relationships hidden across fragmented data - Where AI can connect qualitative patient experiences with quantitative research - Why patient consent complicates how valuable clinical data can be reused - How pharma teams can share knowledge without dismantling every data silo - Why embedding technologists with scientists can accelerate AI adoption - What other industries can learn from pharmaceutical data strategy If you’re responsible for enterprise data or AI strategy, this episode will show you how lessons from pharmaceutical R&D can help turn fragmented information into knowledge that drives better decisions. *Stay in touch with Brian:* Brian Martin on LinkedIn: https://www.linkedin.com/in/brianm1028/ 🔔 Like and subscribe to The AI Forecast, sponsored by Cloudera, to follow our EVOLVE26 Singapore series and stay up to date on the latest conversations about enterprise data and AI. https://www.youtube.com/channel/UCXY5wm6HlBL_Y_8SDxJNR0g?sub_confirmation=1 *Links & Resources* 👉Full Series Playlist: https://www.youtube.com/playlist?list=PLe-h9HrA9qfAmGHgsmXUZgLL-T4Xjhlq8 👉Learn more: https://www.cloudera.com/resources/podcast/the-ai-forecast.html?utm_medium=social-organic&utm_source=youtube&keyplay=cross&utm_campaign=Other---FY27-GLOBAL-Always-On-Cloudera-Podcast&cid=UNGATED&utm_content=youtube-cta *🎧 Listen on your platform of choice:* Spotify: https://open.spotify.com/episode/6fjFcKUYeLGvTwocm5byAp Apple: https://podcasts.apple.com/ie/podcast/can-ai-make-sense-of-pharmas-messiest-data/id1779293119?i=1000789794296 Chapters: 00:00 Intro 00:52 Meet Brian Martin 02:26 Language as Ultimate Technology 04:15 Moving Beyond Tabular SQL Data 08:14 Pharma's Unique Data Complexity 14:18 Pre-Human Research & Clinical Trials 21:00 Building Knowledge Platforms 27:48 Federating Enterprise Data Strategy 33:53 Controlling LLM Hallucinations 36:53 Unifying Knowledge Above Silos *Connect with Cloudera* LinkedIn ► https://www.linkedin.com/company/cloudera Facebook ► https://www.facebook.com/cloudera/ X ► https://twitter.com/cloudera Spotify ► https://open.spotify.com/show/102S8zoZR6nmZV0HxZlxZu #TheAIForecast #AIStrategy #Cloudera #AILeadership #TechGovernance #AIGovernance
 230      1